Last $2.44 USD
Change Today -0.01 / -0.41%
Volume 29.0K
BOTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas D. Richman M.D.

Member of Scientific Advisory Board, Biota Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 128 board members in 10 different organizations across 12 different industries.

See Board Relationships
----

Background*

Dr. Douglas D. Richman, MD is Professor of Pathology and Medicine at the University of California, San Diego School of Medicine and Chief of the Virology Section, Professor and Director of the Research Center for AIDS and HIV Infection at the San Diego VA Medical Center. Dr. Richman has investigated HIV disease and pathogenesis for the past 20 years and was the first to identify HIV drug resistance. He is also a virologist and practicing physician with the Veterans Affairs ...

Read Full Background

Corporate Headquarters*

2500 Northwinds Parkway
Alpharetta, Georgia 30009

United States

Phone: 678-221-3343
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
The Leland Stanford Junior University
Post-Doctoral Training
Harvard University
BA
Dartmouth College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOTA:US $2.44 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Peter Mørch Eriksen BBAChief Executive Officer and Administration Director
BioPorto A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.